Arvinas, Inc. (ARVN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Arvinas, Inc. (ARVN)
Last arvinas, inc. earnings: 11/4 05:00 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Randy Teel - CEO, President & Director Angela Cacace - Chief Scientific Officer Conference Call Participants Etzer Darout - Barclays Bank PLC, Research Division Presentation Etzer Darout Barclays Bank PLC, Research Division Great. Hello again, everyone. I'm Etzer Darout, Senior biotech analyst at Barclays. It's my pleasure to have Arvinas with us for our next session. I have Randy Teel, Chief Executive Officer; and Angela Cacace, Chief Scientific Officer at Arvinas. Question-and-Answer Session Etzer Darout Barclays Bank PLC, Research Division Thank you guys for joining us today. Randy, maybe just give us an overview of Arvinas where you are today, and then we'll jump into Q&A. Randy Teel CEO, President & Director Well. Thank you very much, and thank you to Barclays for having us down here. Yes. So Arvinas, as we start 2026, has 4 programs in Phase 1, which is a pretty exciting pivot for us. Over the past year, we've taken steps to really reposition ourselv
Show less
Read more
Impact Snapshot
Event Time:
ARVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARVN alerts
High impacting Arvinas, Inc. news events
Weekly update
A roundup of the hottest topics
ARVN
News
- Arvinas (ARVN) had its price target raised by Citigroup Inc. from $18.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- Arvinas (ARVN) had its price target raised by BTIG Research from $14.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- Arvinas (ARVN) was given a new $10.00 price target by Truist Financial Corporation.MarketBeat
- Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson's Disease Treated for 28 Days [Yahoo! Finance]Yahoo! Finance
- Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson’s Disease Treated for 28 DaysGlobeNewswire
ARVN
Earnings
- 2/24/26 - Miss
ARVN
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/19/26 - Form 4
- 3/18/26 - Form 8-K
- ARVN's page on the SEC website